Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

While M&A activity slowed in the first quarter of 2025, including in life sciences, there have been plenty of noteworthy developments in the ...

A study of two blockbuster weight-loss drugs showed that users of Eli Lilly’s Zepbound lost just over 2 inches more off their waists compared with Novo Nordisk’s rival Wegovy. Barbara ...

Singer-songwriter Blake Shelton admitted he actually recorded and almost released 'I Wanna Talk About Me', Toby Keith's 2001 ...

HARRISBURG, Pa. (AP) — Gov. Josh Shapiro warned Wednesday that the Medicaid cuts Congress is considering would mean billions of dollars in lost federal aid to Pennsylvania, hundreds of thousands of ...

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head trial of the blockbus… The founder and former CEO of the cryptocurrency lending ...

A blockbuster antitrust trial featuring Meta kicked off in the US last week, with CEO Mark Zuckerberg taking the stand in court to defend the tech giant’s acquisitions of Instagram and WhatsApp over a ...